澳方回应美将对药品加征关税：不符合美国消费者利益

Core Viewpoint - The Australian government criticizes the U.S. decision to impose tariffs on pharmaceuticals, stating it does not align with the interests of American consumers [1] Group 1: Government Response - Australian Health and Aged Care Minister Mark Butler emphasized that the government will support Australian companies potentially affected by "unfair and unreasonable tariffs" [1] - Butler mentioned that the Australian government is currently assessing the impact of the U.S. tariff policy on pharmaceuticals [1] Group 2: Trade Dynamics - Australia imports significantly more pharmaceuticals from the U.S. than it exports, highlighting the imbalance in trade [1] - In the previous year, Australia's pharmaceutical exports to the U.S. amounted to approximately 2.1 billion Australian dollars [1] Group 3: U.S. Tariff Announcement - U.S. President Trump announced a 100% tariff on all imported brand-name or patented drugs starting October 1, unless companies establish manufacturing facilities in the U.S. [1]